Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies
- Status
- COMPLETED
- Phase
- NA
Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab and Olaparib in Bile Duct Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1 In-vivo Biliary Study of KSP/QRH Heptapeptide Dimer
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Effect and Safety of PDT and RFA for Unresectable EHCC
- Status
- COMPLETED
- Phase
- NA
Pemigatinib in Treating Patients With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Including FGFR2 Rearrangement
- Status
- COMPLETED
- Phase
- PHASE2
Diagnosis, Treatment Status and Prognosis of Cholangiocarcinoma in China: a Multicenter, Two-way, Non-intervention Study
- Status
- UNKNOWN
- Phase
- N/A
A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion
- Status
- COMPLETED
- Phase
- PHASE2
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
National Translational Science Network of Precision-based Immunotherapy for Primary Liver Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
PCI Treatment/Gemcitabine & Chemotherapy vs Chemotherapy Alone in Patients With Inoperable Extrahepatic Bile Duct Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers
- Status
- TERMINATED
- Phase
- NA
Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2